featured
Gene Therapy for Adenosine Deaminase Deficiency
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
N. Engl. J. Med 2021 May 27;384(21)2002-2013, DB Kohn, C Booth, KL Shaw, J Xu-Bayford, E Garabedian, V Trevisan, DA Carbonaro-Sarracino, K Soni, D Terrazas, K Snell, A Ikeda, D Leon-Rico, TB Moore, KF Buckland, AJ Shah, KC Gilmour, S De Oliveira, C Rivat, GM Crooks, N Izotova, J Tse, S Adams, S Shupien, H Ricketts, A Davila, C Uzowuru, A Icreverzi, P Barman, B Campo Fernandez, RP Hollis, M Coronel, A Yu, KM Chun, CE Casas, R Zhang, S Arduini, F Lynn, M Kudari, A Spezzi, M Zahn, R Heimke, I Labik, R Parrott, RH Buckley, L Reeves, K Cornetta, R Sokolic, M Hershfield, M Schmidt, F Candotti, HL Malech, AJ Thrasher, HB GasparFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.